The Study
Response to Allopurinol and Febuxostat According to the Fractional Excretion of Urate in Men With Gout
This study looked at a group of men with gout and noticed that those whose kidneys reabsorb more uric acid tended to respond better to one medicine (allopurinol). But it didn’t make people take the medicine — it just watched what happened. So we can say the two things are linked, but we can’t say one causes the other.
Analysis score
Maximum 72 for a cohort study.
Where the score came from
This study looked at why some men with gout lower their uric acid better with allopurinol than others.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 559 / 100
Quality score
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
Key takeaways
Summary
Based on the study abstract and findings.
- 1This difference is small but meaningful—it means doctors might predict who benefits most from allopurinol by checking how well their kidneys excrete uric acid.
- 2Men with low uric acid excretion (FEUA ≤5.5%) had 6.4 μM more uric acid drop per 150 mg extra allopurinol than those with high excretion.
- 3Their blood had more active drug (oxypurinol).
- 4Febuxostat worked the same regardless of excretion.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Arthritis Care & Research
Year
2025
Authors
Pascal Richette, A. Walter-Petrich, Q. Nguyen, Matthieu Resche-Rigon, Q. Nguyen, M. Do, Thao Phuong Mai, T. D. Nguyen, F. Pérez-Ruiz, Emmanuel Letavernier, Tristan Pascart, A. Latourte, Hang-Korng Ea, Thomas Bardin
Related Content
Claims (6)
In men with gout and normal kidney function, those who excrete less uric acid in their urine (FEUA ≤5.5%) experience a larger drop in blood urate levels when given higher doses of allopurinol than those who excrete more uric acid, because their kidneys clear the active drug metabolite oxypurinol less effectively.
In men with gout and normal kidney function, lower urinary excretion of uric acid correlates with higher blood levels of oxypurinol, suggesting that the same kidney processes that reabsorb uric acid also reabsorb oxypurinol.
In men with gout and normal kidney function, the amount of uric acid removed by the kidney tubules does not depend strongly on how well the kidney filters blood, meaning these two processes work separately to control uric acid excretion.
In men with gout and normal kidney function, the amount of uric acid cleared by the kidneys does not affect how much febuxostat lowers blood uric acid levels.
In men with gout and normal kidney function, the amount of uric acid cleared by the kidneys predicts how well allopurinol will reduce uric acid levels, even after accounting for body weight and kidney filtering capacity.
Allopurinol decreases the amount of uric acid in the blood by increasing how much uric acid the kidneys remove through urine.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.